Aurora Cannabis Looks To Raise US$125 Million Via Bought Deal

Some degree of investor demand evidently remains within the Canadian cannabis sector. Aurora Cannabis (TSX: ACB) last night announced that it will be conducting a rather large financing, which is to take the form of a bought deal.

The financing will see the company raise gross proceeds of US$125.0 million. Led by Canaccord Genuity and BMO Capital Markets, the financing will consist of units priced at US$2.45 per each.

Each unit is to contain one common share and one common share purchase warrant. Each warrant is valid for a period of three years from the date of issuance, and contains an exercise price of US$3.20 per share. A total of 51.1 million units are to be sold under the offering.

A 15% over-allotment option has also been granted in connection with the financing.

Proceeds from the financing are to be used for general corporate purposes. The financing is currently slated to close June 1.

The company reported a cash position of C$429.9 million as of March 31, although subsequent to quarter end it spent C$122.9 million on May 9 redeeming outstanding senior notes.

Aurora Cannabis last traded at $3.47 on the TSX.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization unless otherwise mentioned. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

2026 Could Be Gold’s Biggest Year Yet!? | Ryan King – Equinox Gold

Gold Is Screaming Higher While Currencies Burn | Simon Ridgway – Rackla Metals

We Have the Highest-Grade Antimony Deposit in North America!? | Jim Atkinson -Antimony Resources

Recommended

Canadian Copper Secures $8 Million Lead Order From Ocean Partners As Part Of Larger Funding Round

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Related News

Aurora Exports $10 Million In Cannabis To Israel

Aurora Cannabis (TSX: ACB) seemingly remains focused on growing its international medical cannabis operation. The...

Tuesday, January 4, 2022, 08:07:20 AM

Aurora Cannabis To Shutter Five Facilities, Faces Impairments of $200 Million

Aurora Cannabis (TSX: ACB) (NYSE: ACB) this morning released an update in relation to its...

Tuesday, June 23, 2020, 11:32:30 AM

Aurora Cannabis, New Gold Amid Names Dropped From S&P/TSX Composite In Latest Rebalance

Details on the latest quarterly adjustments to the S&P/TSX Composite Index, as well as the...

Saturday, September 3, 2022, 11:11:00 AM

Cronos Group Licenses IP From Aurora Cannabis, 22nd Century Group Related To Biosynthesis

Aurora Cannabis (TSX:ACB) has reportedly entered into a licensing arrangement with 22nd Century Group (NASDAQ:...

Wednesday, December 15, 2021, 09:21:00 AM

Aurora Cannabis: Analysts Raise Price Targets Following Q1 Results

Yesterday, Aurora Cannabis (TSX: ACB) (NYSE: ACB) reported their first quarter 2021 results. Aurora reported...

Tuesday, November 10, 2020, 03:21:00 PM